Company profile
Connect Biopharma Holdings Limited
NASDAQ: CNTB · Healthcare · Biotechnology
PublicHQ San Diego, CIK 0001835268Reports USD
#1070 of 1,417 Healthcare companies by revenuebottom-decile growth
EA Score
25DFH 28DQ 15GM —SS 47
v0.1 · 55/100 weight · provisional
↑ balance-sheet leverage, market scale · ↓ Piotroski F, operating margin
Methodology →Revenue TTM
$24.9M
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$55.5M
Employees
64
as of 2026-07-19
Market cap
$142.3M
as of 2026-07-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$64.0k$64.0k2025
Net income-$55.5M-$55.5M2025
Operating income-$58.1M-$58.1M2025
Total assets$56.1M$56.1M2025
Liabilities$14.1M$14.1M2025
Equity$42.0M$42.0M2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
License100%
By geography
Not disclosed.
The read
What is Connect Biopharma Holdings Limited’s revenue?
Connect Biopharma Holdings Limited booked $64.0k in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -86687.5% net margin.
Peers · Healthcare
Aquarius Surgical Technologies Inc.——Inovio Pharmaceuticals, Inc.37DKali, Inc.——Oxford Investments Holdings Inc.——Real Brands, Inc.——Avalo Therapeutics, Inc.41DKey facts
CEOBarry D. Quart
SectorHealthcare
IndustryBiotechnology
HeadquartersSan Diego, null
ExchangeNASDAQ: CNTB
Employees64
IPO date2021-03-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.